Abstract
Pancreatic cancer is well known to have a short duration of survival after diagnosis, and despite advances in treatment and therapies, little progress has been made regarding the outcome of prolonging quantity of life. Indeed, the majority of patients (80%) will receive palliative medical or surgical interventions aimed at control of symptoms only. Within this context of limited survival, quality of life assumes great importance. Clinicians should be concerned not only with advancing knowledge regarding the biophysical disease process but also with the consequences of illness on the well-being of their patients and how the patients cope with their illness, treatment and care. Such knowledge can only help to advance our understanding of pancreatic cancer.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Aaronson NK, Meyerowitz BE, Bard M et al. (1991) Quality of life research in oncology: past achievements and future priorities. Cancer 67:839–843.
Aaronson NK, Cull A, Kaasa S, Sprangers MA (1994) The European Organisation for Research and Treatment of Cancer (EORTC) modular approach to quality of life assessment in oncology: an update. In: Spilker B (ed) Quality of life and pharmacoeconomics in clinical trials, 2nd edn. Raven Press, New York.
Ahlgren JD (1996) Chemotherapy for pancreatic carcinoma. Cancer 78:654–663.
Alter CL (1996) Palliative and supportive care of patients with pancreatic cancer. Semin Oncol 23:229–240.
Andersen JS, Burris HA, Casper E et al. (1994) Development of a new system for assessing clinical benefit for patients with advanced pancreatic cancer. Proc Am Soc Clin Oncol 13:461 (abstract).
Bakkevold KE, Kambestad B (1995) Palliation of pancreatic cancer. A prospective multicentre study. Eur J Surg Oncol 21:176–182.
Ballinger AB, McHugh M, Catnach SM, Alstead EM, Clark ML (1994) Symptom relief and quality of life after stenting for malignant bile duct obstruction. Gut 35:467–470.
Ballinger AB, McHugh M, Catnach SM et al. (1994) Symptom relief and quality of life after stenting for malignant bile duct obstruction. Gut 35:476–470.
Bloechle C, Izbicki JR, Knoefel WT et al. (1995) Quality-of-life in chronic-pancreatitis — results after duodenum-preserving resection of the head of the pancreas. Pancreas 11:77–85.
Bowling A (1991) Measuring health: a review of quality of life measurement scales. Open University Press, Buckingham.
Bowling A (1991) Measuring disease. Open University Press, Buckingham.
Carter JP, Saxe GP, Newbold V, Peres CE, Campeau RJ, Bernal Green L (1993) Hypothesis: dietary management may improve survival from nutritionally linked cancers based on analysis of representative cases. J Am Coll Nutr 12:209–226.
Carter DC (1995) Clinical features and management of carcinoma of the pancreas. Br J Hosp Med 54:459–464.
Celia DF (1994) Quality of life: concepts and definitions. J Pain Symptom Management 9:186–192.
De Wys WD (1986) Weightloss and nutritional abnormalities in cancer patients: incidence, severity and significance. In: Calman KC, Fearon KCH (eds) Nutritional support for the cancer patient. Bailliére Tindall, London.
Dunkel-Schatter C, Feinstein LG, Taylor SE, Falke RL (1991) Patterns of coping with cancer. Health Psychol 11:79–87.
Ebert M, Friess H, Beger HG, Büchler M (1994) Role of octreotide in the treatment of pancreatic cancer. Digestion 55 (Suppl 1):48–51.
Fallowfield L (1990) Quality of life: the missing measurement in health care. Souvenir Press, London.
Faulkner A, Maguire P (1994) Talking to cancer patients and their families. Oxford Medical Publications, Oxford.
Fitzsimmons D (1998) Differences in perception of quality of life issues between health professionals and patients with pancreatic cancer. Psycho-Oncology (in press).
Gammon J (1991) Which way out of the crisis? Professional Nurse May:488–493.
Glaser BG and Strauss AL (1986) The discovery of grounded theory: strategies for qualitative research. Aldine, Chicago.
Glimelius B, Hoffman K, Graf W et al. (1995) Cost-effectiveness of palliative chemotherapy in advanced gastrointestinal cancer. Ann Oncol 6:267–274.
Glimelius B, Hoffman K, Sjoden PO et al. (1996) Chemotherapy improves survival and quality-of-life in advanced pancreatic and biliary cancer. Ann Oncol 7:593–600.
Hopkins A (1992) Measures of quality of life and the uses to which such measures may be put. Royal College of Physicians, London.
Ishikawa O, Ohigashi H, Nakaizumi A et al. (1993) Surgical resection of potentially curable pancreatic cancer with improved preservation of endocrine function: further evaluation of intraoperative cytodiagnosis. Hepatogastroenterology 40:443–447.
Jaloweic A (1990) Issues in using multiple measures of quality of life. Semin Oncol Nursing 6:271–277.
Karnofsky DA, Abelman WH, Craver LF et al. (1948) The use of nitrogen mustards in the palliative treatment of carcinoma. Cancer 1:634–656.
Kawamata M, Ishitani K, Ishikawa K et al. (1996) Comparison between celiac plexus block and morphine treatment on quality of life in patients with pancreatic cancer pain. Pain 64:597–602.
Kelsen DP, Portenoy RK, Thaler HT (1995) Pain and depression in patients with newly diagnosed pancreas cancer. J Clin Oncol 13:748–755.
Krech RL, Walsh D (1991) Symptoms of pancreatic cancer. J Pain Symptom Management 6:360–367.
Lancet Editorial (1995) Quality of life and clinical trials. Lancet 346:1–2.
Lebovits AH and Lefkowitz M (1989) Pain management of pancreatic carcinoma: a review. Pain 36:1–11.
Lebovits AH, Lefkowitz M (1988) Pain management of pancreatic carcinoma: a review. Pain: 36,1–11.
Lionetto R, Pugliese V, Bruzzi P and Rosso R (1995) No standard treatment is available for advanced pancreatic cancer. Eur J Cancer 31A:882–887.
Lionetto R, Pugliese V, Bruzzi P, Rosso R (1995) No standard treatment is available for advanced pancreatic cancer. Eur J Cancer 31A:882–887.
Luman W, Cull A, Palmer KR (1996) Quality of life following endoscopic stenting for malignant biliary obstruction. Abstract Presented at the British Society of Gastroenterology, Brighton, March, 1996.
Maguire (1992) Improving the recognition and treatment of affective disorders in cancer patients. In: Granville-Grasson K (ed) Recent advances in psychiatry 7. Churchill Livingstone, Edinburgh.
Maguire P (1985) Barriers to psychological care of the dying. BMJ 291:1711–1713.
McLaughlin S. (1994) Pancreatic cancer and diabetes. Diabetes Educ. 20, 20, 24, 26.
McLeod RS. Taylor BR. O’Connor BI et al. (1995) Quality of life, nutritional status, and gastrointestinal hormone profile following the Whipple procedure. Am J Surg 169:179–85
Moore H (1996) Activity of gemcitibine in patients with advanced pancreatic carcinoma. Cancer 78:633–638.
Newman, I, McDowell C (1992) A guide to rating scales and questionnaires. Oxford University Press, Oxford.
Niezgoda HE, Pater JL (1993) A validation study of the domains of the core EORTC quality of life questionnaire. Qual Life Res 2:129–148.
Ottery F (1996) Supportive nutritional management of the patient with pancreatic cancer. Oncology 10:26–32.
Palmer KR, Kerr M, Knowles G, Cull A et al. (1994) Chemotherapy prolongs survival in inoperable pancreatic carcinoma. Br J Surg 81:882–885.
Passik SD and Breitbart WS (1996) Depression in patients with pancreatic carcinoma. Diagnostic and treatment issues. Cancer 78:615–626.
Portenoy RK (1991) Pain and quality of life: clinical issues and implications for research. In: Tchelmedigion NS and Cella DF (eds) Quality of life in oncology: practice and research. New York.
Ringdal GI, Ringdal K (1993) Testing the EORTC quality of life questionnaire on cancer patients with heterogeneous diagnoses. Qual Life Res 2:129–140.
Schumate CR, Baron TH (1996) Palliative procedures for pancreatic cancer: when and which one? South Med J 89:27–32.
Schoeman MN, Huibregtse K (1995) Pancreatic and ampullary carcinoma. [Review.] Gastro-intest Endosc Clin North Am 5(1):217–236.
Singh SM, Reber HA (1989) Surgical palliation for pancreatic cancer. Surg Clin North Am 69:599–611.
Slevin ML (1992) Quality of life: philosophical question or clinical reality? Br Med J 305:466–469.
Strauss A, Corbin J (1990) Basics of qualitative research: grounded theory procedures and techniques. Sage, New York.
Sugarbaker PH, Barosky I, Rosenberg SA, Gianola FJ (1982) Quality of life assessment of patients in extremity sarcoma clinical trials. Surgery 91:17–23.
Tamura K, Kin S, Nagami H et al. (1992) Heterotopic autotransplantation of the distal pancreas segment after total pancreatectomy for cancer of the head of the pancreas. Pancreas 7:664–671.
Taylor OM, Benson EA, McMahon MJ. 1993. Clinical trial of tamoxifen in patients with irresectable pancreatic adenocarcinomavThe Yorkshire Gastrointestinal Tumour Group. Br J Surg 80:384–386.
Trede M, Carter DC (1987) Surgery of the pancreas. Churchill Livingstone, Edinburgh.
Watanapa P, Williamson RCN (1992) Surgical palliation for pancreatic cancer: developments during the past two decades. Br J Surg 79:8–20.
Webster S, Johnson CD (1994) Quality of life in pancreatic cancer. Fourth-year medical student study-in-depth project. University of Southampton (unpublished).
Yasue M, Sakamoto J, Morimoto T et al. (1995) Evaluation of the effect of pancreatic resection in advanced pancreatic cancer with special reference using hospital-free survival as a measure of quality of life. Jpn J Clin Oncol 25:37–45.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1999 Springer-Verlag London Limited
About this chapter
Cite this chapter
Fitzsimmons, D., Johnson, C.D. (1999). Quality of Life Assessment in Pancreatic Cancer. In: Johnson, C.D., Imrie, C.W. (eds) Pancreatic Disease. Springer, London. https://doi.org/10.1007/978-1-4471-0801-6_40
Download citation
DOI: https://doi.org/10.1007/978-1-4471-0801-6_40
Publisher Name: Springer, London
Print ISBN: 978-1-4471-1205-1
Online ISBN: 978-1-4471-0801-6
eBook Packages: Springer Book Archive